Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 1, 2010, Pages 62-67

  Mercolini, Laura ^a   Mandrioli, Roberto ^a   Amore, Mario ^b   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Gabapentin; HPLC F; Therapeutic drug monitoring; Topiramate; Vigabatrin

Indexed keywords

ACETONITRILE; AMISULPRIDE; AMITRIPTYLINE; AMOXAPINE; ANTICONVULSIVE AGENT; BONDELUT PLEXA; BUFFER; CHLORPROMAZINE; CLOMIPRAMINE; CLOTIAPINE; CLOZAPINE; DANSYL CHLORIDE; FLUOXETINE; GABAPENTIN; HALOPERIDOL; ISONIAZID; LEVOMEPROMAZINE; MAPROTILINE; MIRTAZAPINE; OASIS; PAROXETINE; PHOSPHATE; POLYMER; PROMAZINE; QUETIAPINE; SERTRALINE; SULPIRIDE; TOPIRAMATE; TRAZODONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VIGABATRIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG STRUCTURE; EPILEPSY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; STRUCTURE ANALYSIS;

AMINES; ANTICONVULSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANECARBOXYLIC ACIDS; DANSYL COMPOUNDS; DRUG MONITORING; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LIMIT OF DETECTION; SPECTROMETRY, FLUORESCENCE; VIGABATRIN;

EID: 77952319514     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.02.036     Document Type: Article

References (25)

1. Vajda F.J. New antiepileptic drugs. Clin. Neurosci. 2000, 7:88-101.
2. Citrome L. Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?. Exp. Rev. Neurother. 2009, 9:55-71.
3. Rogawski A., Löscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 2004, 5:553-564.
4. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. 2004, 3:618-621.
5. Martindale-The Complete Drug Reference 2009, 482-483. Pharmaceutical Press, London. 36th ed. S.C. Sweetman (Ed.).
6. Baulac M., Cavalcanti D., Semah F., Arzimanoglou A., Portal J.J. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. Seizure 1998, 7:55-62. The French Gabapentin Collaborative Group.
7. Kwan P, Brodie M.J. Epilepsy after the first drug fails: substitution or add-on?. Seizure 2000, 9:464-468.
8. Arvio M., Sillanpää M. Topiramate in long-term treatment of epilepsy in the intellectually disabled. J. Intell. Disabil. Res. 2005, 49:183-189.
9. Jalalizadeh H., Souri E., Tehrani M.B., Jahangiri A. Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene and its application to a pharmacokinetic study. J. Chromatogr. B 2007, 854:43-47.
10. Sagirli O., Cetin S.M., Onal A. Determination of gabapentin in human plasma and urine by high-performance liquid chromatography with UV-vis detection. J. Pharmaceut. Biomed. 2006, 42:618-624.
11. Bahrami G., Mohammadi B. Sensitive microanalysis of gabapentin by high-performance liquid chromatography in human serum using pre-column derivatization with 4-chloro-7-nitrobenzofurazan: application to a bioequivalence study. J. Chromatogr. B 2006, 837:24-28.
12. Chung T.C., Tai C.T., Wu H.L. Simple and sensitive liquid chromatographic method with fluorimetric detection for the analysis of gabapentin in human plasma. J. Chromatogr. A 2006, 1119:294-298.
13. Hsieh C.Y., Wang S.Y., Kwan A.L., Wu H.L. Fluorescent high-performance liquid chromatographic analysis of vigabatrin enantiomers after derivatizing with naproxen acyl chloride. J. Chromatogr. A 2008, 1178:166-170.
14. Franco V., Mazzucchelli I., Fattore C., Marchiselli R., Gatti G., Perucca E. Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. J. Chromatogr. B 2007, 854:63-67.
15. Cetin S.M., Atmaca S. Determination of vigabatrin in human plasma and urine by high-performance liquid chromatography with UV-vis detection. J. Chromatogr. A 2004, 1031:237-242.
16. Bahrami G., Mohammadi B. A novel high sensitivity HPLC assay for topiramate, using 4-chloro-7-nitrobenzofurazan as pre-column fluorescence derivatizing agent. J. Chromatogr. B 2007, 850:400-404.
17. Williams J., Bialer M., Johannessen S.I., Kramer G., Levy R., Mattson R.H., Perucca E., Patsalos P.N., Wilson J.F. Interlaboratory variability in the quantification of new-generation antiepileptic drugs based on external quality assessment data. Epilepsia 2003, 44:40-45.
18. Oertel R., Arenz N., Pietsch J., Kirch W. Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. J. Sep. Sci. 2009, 32:238-243.
19. Borrey D.C., Godderis K.O., Engelrelst V.I., Bernard D.R., Langlois M.R. Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry. Clin. Chim. Acta 2005, 354:147-151.
20. Vermeij T.A., Edelbroek P.M. Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. J. Chromatogr. B 2004, 810:297-303.
21. Krivanek P., Koppatz K., Turnheim K. Simultaneous isocratic HPLC determination of vigabatrin and gabapentin in human plasma by dansyl derivatization. Ther. Drug Monit. 2003, 25:374-377.
22. United States Pharmacopeia 2009, United States Pharmacopeial Convention, Rockville, pp. 733-736. 32nd ed.
23. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., Mckay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Bioanalytical method validation-a revisit with a decade of progress. Pharm. Res. 2000, 17:1551-1557.
24. Johannessen S.I., Battino D., Berry D.J., Bialer M., Kraemer G., Tomson T., Patsalos P.N. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther. Drug Monit. 2003, 25:347-363.
25. Sánchez-Alcaraz A., Quintana B., Rodriguez I., López E. Plasma concentrations of vigabatrin in epileptic patients. J. Clin. Pharm. Ther. 1996, 21:393-398.